DELIVERING CURE

Welcome to the Brand page for “DELIVERING CURE”, which is offered here for Pharmaceutical products in the nature of biological preparations for use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, vaccines for use in gene therapy; pharmaceutical products for use in gene therapy and prophylaxis, gene delivery, gene transfer, gene regulation and gene modulation preparations for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, cancer, inflammatory and auto-immune diseases, vascular disorders, and single gene disorders;.

Its status is currently believed to be active. Its class is unavailable. “DELIVERING CURE” is believed to be currently owned by “Amsterdam Molecular Therapeutics (AMT) Holding N.V.”